<DOC>
	<DOCNO>NCT03022747</DOCNO>
	<brief_summary>The study investigate , child acute lymphoblastic leukemia maintenance treatment , addition allopurinol conventional oral 6-mercaptopurine methotrexate therapy , affect erythrocyte concentration 6-thioguanine 6 methylmercaptopurine . The effect hematological liver toxicity parameter blood also investigate well clinical toxicity .</brief_summary>
	<brief_title>Optimizing 6-mercaptopurine Therapy Pediatric Acute Lymphoblastic Leukemia Using Allopurinol</brief_title>
	<detailed_description>After one month conventional maintenance therapy ( MT ) child adolescent , treat acute lymphoblastic leukemia Nordic protocols wild type thiopurine methyltransferase ( TPMT ) eligible study . They first receive 12 week phase normal MT time repeat sample 6-mercaptopurine ( 6MP ) metabolite level laboratory parameter perform . After 12 week , allopurinol dose 50 mg/sqm add ( simultaneously reduce dose 6MP 50 % ) next 12 week patient monitor closely toxicity sample determination metabolite level hematological liver toxicity obtain regularly . If , 4 week allopurinol treatment , level 6-thioguanine 200 nmol/mmol hemoglobin , dose allopurinol increase 100 mg/sqm . Allopurinol treatment continue 12 week patient switch original maintenance therapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Confirmed diagnosis acute lymphoblastic leukemia Treatment accord Nordic Society pediatric hematology/oncology ( NOPHO ) ALL2008 base protocol Age 018y time initial diagnosis TPMT wild type Written inform consent Mature B cell lymphoblastic leukemia ( 9 ; 22 ) positive acute lymphoblastic leukemia Unknown TPMT status presence TPMT mutation ( heterozygous homozygous ) Known intolerance chemotherapeutic drug protocol Major organ failure preclude administration plan chemotherapy Severe liver toxicity define persistent ( ≥ two week ) elevation either Sbilirubin &gt; 50 μmol/l SGPT &gt; 20 x Upper normal limit ( UNL ) PProthrombin complex &gt; 1.5 . Reduced kidney function define Screatinine ≥ 1.5 x UNL . Lactating female female childbearing potential use adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>